miRNA-based diagnostics

The five-year-old firm recently completed a clinical trial of the real-time PCR-based test, called ProALL-BM, on patients from a European National Registry Study.

NEW YORK (GenomeWeb) – Cantor Fitzgerald today initiated coverage of miRNA-based diagnostics firm Rosetta Genomics with a Hold rating and a $4 price target on the company's stock.

NEW YORK (GenomeWeb) – PDI said after the close of the market Wednesday that its Interpace Diagnostics subsidiary will enter the molecular diagnostics market through the acquisition of two microRNA-based from Asuragen.

NEW YORK (GenomeWeb) – Molecular diagnostics developer DiamiR said today it has received a grant from the Michael J. Fox Foundation for Parkinson's Research for a study to validate the use of microRNA biomarkers for detecting Parkinson's early.

NEW YORK (GenomeWeb) – Trovagene has assigned all of its miRNA patents to London-based firm GenSignia IP and licensed back the technology, the San Diego-based company disclosed in its Form 10-Q filed with the US Securities and Exchange Commission recently.

NEW YORK (GenomeWeb News) – Exiqon today reported a 5 percent increase year over year in its revenues for 2013, while revenues in its fourth quarter shrank 16 percent.

NEW YORK (GenomeWeb News) –Rosetta Genomics today announced it has executed credentialing agreements with two preferred provider organizations for its Cancer Origin Test.

NEW YORK (GenomeWeb News) – Blood expression levels of a dozen microRNAs may help in distinguishing individuals affected by Alzheimer's disease from those who aren't, according to a study appearing online today in Genome Biology.

NEW YORK (GenomeWeb News) – Rosetta Genomics said after the close of the market on Thursday it and Precision Therapeutics have amended their co-marketing deal entered into in July 201

NEW YORK (GenomeWeb News) – Partners in Denmark have joined to embark on a €5.2 million ($6.8 million) personalized cancer diagnostic project.

Pages

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.